Rankings
▼
Calendar
OMER Q3 2020 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena
OMER
Omeros Corporation
$821M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$26M
-12.5% YoY
Gross Profit
$26M
98.5% margin
Operating Income
-$25M
-97.4% margin
Net Income
-$38M
-147.3% margin
EPS (Diluted)
$-0.66
QoQ Revenue Growth
+93.0%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$227M
Total Liabilities
$314M
Stockholders' Equity
-$87M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$26M
$30M
-12.5%
Gross Profit
$26M
$30M
-13.1%
Operating Income
-$25M
-$11M
-129.1%
Net Income
-$38M
-$16M
-133.6%
← FY 2020
All Quarters
Q4 2020 →